KARYN SCHALET: Open Payments
NPI 1669603049 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $850
Food & beverage: $760Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $247 |
| Kerecis Limited | 2 | $165 |
| Regeneron Healthcare Solutions, Inc. | 2 | $96 |
| Incyte Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $62 |
| Galderma Laboratories, L.P. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| UCB, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Biofrontera Inc. | 1 | $22 |
Products named: SKYRIZI, Kerecis SurgiClose, DUPIXENT, RINVOQ, OPZELURA, TALTZ, Sotyktu, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
